Choriocarcinoma

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Choriocarcinoma | |
|---|---|
| |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Vaginal bleeding, abdominal pain, cough, hemoptysis |
| Complications | Metastasis to lungs, brain, liver |
| Onset | Typically after pregnancy |
| Duration | Variable |
| Types | N/A |
| Causes | Gestational trophoblastic disease |
| Risks | Prior molar pregnancy, age extremes in pregnancy |
| Diagnosis | Beta-HCG levels, imaging studies |
| Differential diagnosis | Ectopic pregnancy, molar pregnancy, germ cell tumor |
| Prevention | N/A |
| Treatment | Chemotherapy, surgery |
| Medication | N/A |
| Prognosis | Generally good with treatment |
| Frequency | Rare |
| Deaths | N/A |





Choriocarcinoma is a fast-growing cancer that occurs in a woman's uterus (womb). The abnormal cells start in the tissue that would normally become the placenta. The placenta is the organ that develops during pregnancy to feed the fetus. Choriocarcinoma is a type of gestational trophoblastic disease (GTD), a group of conditions that occur when tumors develop in the cells that would normally form the placenta during pregnancy. Although rare, choriocarcinoma can be extremely aggressive and spread rapidly to other parts of the body.
Causes and Risk Factors[edit]
Choriocarcinoma most commonly follows a molar pregnancy, a pregnancy in which the placenta develops into an abnormal mass of cysts. However, it can also develop after a normal pregnancy, miscarriage, ectopic pregnancy, or abortion. Risk factors for developing choriocarcinoma include a previous molar pregnancy, especially if it was complete rather than partial, and age (women older than 35 and younger than 20 are at higher risk).
Symptoms[edit]
Symptoms of choriocarcinoma may include vaginal bleeding that is not related to a menstrual period, an enlarged uterus, and symptoms related to metastasis (spread of cancer) such as shortness of breath, cough, and hemoptysis (coughing up blood). Due to its aggressive nature, choriocarcinoma can quickly spread to other organs, including the lungs, liver, brain, and kidneys.
Diagnosis[edit]
Diagnosis of choriocarcinoma involves a combination of medical history, physical examination, ultrasound of the uterus, and blood tests to measure levels of human chorionic gonadotropin (hCG), a hormone produced during pregnancy. High levels of hCG can indicate the presence of choriocarcinoma. In some cases, a biopsy of the uterus may be performed to confirm the diagnosis.
Treatment[edit]
Treatment for choriocarcinoma typically involves chemotherapy, which can be highly effective. Surgery may be required to remove the tumor if it is localized. In cases where the cancer has spread to other organs, a combination of chemotherapy and surgery may be necessary. The choice of treatment depends on the stage of the cancer and whether it has spread.
Prognosis[edit]
The prognosis for choriocarcinoma can vary widely depending on the stage of the cancer at diagnosis and how well it responds to treatment. With early detection and appropriate treatment, the prognosis is generally good, and many women can go on to have normal pregnancies in the future.
Prevention[edit]
There are no specific ways to prevent choriocarcinoma. However, regular medical check-ups and prompt attention to symptoms such as unusual vaginal bleeding can help in early detection and treatment, improving the chances of a favorable outcome.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
